ArticleOncotarget2020

Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancer.

Marina P Antoch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.